Skip to main content
Premium Trial:

Request an Annual Quote

CalbaTech Acquires MolecularWare

NEW YORK, June 9 - Biotech incubator CalbaTech said today that it has agreed to acquire privately held bioinformatics firm MolecularWare.


Financial terms of the acquisition were not disclosed.


CalbaTech said that MolecularWare, which markets a suite of software tools called DigitalGenome, was a key acquisition target because it "validates CalbaTech's business model in which it is seeking to acquire life-sciences-based companies that have near-term revenue or already have revenue and need a modest infusion of capital and a new structure."


CalbaTech's mission is to incubate companies that will generate sales or licensing revenues within two years and that require less than $1 million to bring a product to market. To date, the company has completed two other technology acquisition agreements: A license to slide-based diagnostics technology from Scottish diagnostics firm QICC; and a DNA isolation and extraction technology developed by J. Zoval, an associate inventor with CalbaTech.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.